vimarsana.com
Home
Live Updates
C Difficile Therapy Is Efficacious, Safe in Immunocompromise
C Difficile Therapy Is Efficacious, Safe in Immunocompromise
C Difficile Therapy Is Efficacious, Safe in Immunocompromised Patients
The Clostridioides difficile study was presented at Digestive Disease Week in Chicago.
Related Keywords
Chicago ,
Illinois ,
United States ,
,
Fecal Microbiota ,
Reducing Recurrent Clostridioides ,
Immunocompromised Participants ,
Digestive Disease Week ,
Anatomical Therapeutic Chemical ,
C Difficile ,
Clostridioides Difficile Infection ,
Immunocompromised ,